Healthcare - Press Releases

Winston-Salem-based Digital Health Company Receives Two Prestigious Awards at ViVE Event in Nashville, TN

GALWAY, Ireland, March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) onThursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal year 2025 of $0.70per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company inMay 2024. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 47 consecutive years. The dividend is payable onApril 11, 2025, to shareholders of record at the close of business onMarch 28, 2025.

--Dosing ongoing in Phase 1 clinical trial cohorts evaluating Claudin 18.2 ADC EO-3021 in combination with ramucirumab or dostarlimab in patients with advanced gastric/gastroesophageal junction (GEJ) cancer --

MEXICO CITY, March 6, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V.(BMV: LABB)("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on March 14, 2025. This amount per share is based on the total LABB shares currently outstanding.

Fort Lauderdale business owner recognized by world's oldest and largest franchising association during Annual Convention in Las Vegas; Recognized for excellence in business, giving back, and providing opportunities to those around them.

Daniel M. Skovronsky, MD, PhD, of Eli Lilly & Company, Receives Prestigious 2025 Melvin R. Goodes Prize, Nobel Prize of Alzheimer's Research

With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but TEPMETKO's once-daily dosing and efficacy profile offer differentiation.

The increasing prevalence of neurological disorders, such as cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs), is the key factor fueling the demand for interventional neuroradiology. As these conditions become more common, there is a growing need for minimally invasive diagnostic and treatment methods to enhance patient outcomes and shorten recovery periods.

GREENWOOD VILLAGE, Colo., March 6, 2025 /PRNewswire/ -- Catalyst Solutions, a leader in innovative health plan optimization, announced today that Lisa Hettinger has joined the company as a member of the Advisory Board focused on Government Solutions. Hettinger brings more than 30 years of leadership experience in healthcare, including a distinguished tenure as Chief Financial Officer and State Medicaid Director at the Idaho Department of Health and Welfare.

VANCOUVER, BC, March 6, 2025 /PRNewswire/ -GBM Health Holding, a global leader in integrated healthcare innovation, is proud to announce that its subsidiariesGene Biotechnology Enterprises Ltd(Operating business as: "Gene Bio Medical")and Geno10X Bioscience Inchave been awarded a combined $1.5 million CAD in funding from Innovate BC. The grants, part of Innovate BC's Ignite Program, will accelerate the development of cutting-edge clean technology and life sciences solutions poised to transform healthcare and environmental sustainability.

Get $31.30 Off Any Purchase of $125 in Celebration of 313 Day

WASHINGTON, March 6, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle,Kumapley Lartevi, MD is acknowledged as a 2025 Pinnacle Lifetime Member for his contributions to Providing Quality Care to the Community.

MANDEVILLE, La., March 6, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, James W. Christopher, MD, FACS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Surgeon Committed to Excellence in Minimally Invasive Surgery.

The network is bringing together thought leaders, branding experts, and healthcare professionals in their Paris Village to explore the latest transformational impact of GLP-1 treatments emerging and disrupting the European market.

NASHVILLE, Tenn., March 6, 2025 /PRNewswire/ -- SLD Technology, a major sponsor, in collaboration with the Association of Medical Facility Professionals (AMFP) and SquareFootage.net is proud to present the 2025 D4Z Healthcare Summit, an exclusive industry event dedicated to advancing healthcare design, innovation and the reduction of healthcare harm. Taking place at the Omni Hotel in Nashville, TN, this non-profit event will donate all net proceeds to St. Jude Children's Hospital, supporting its mission to treat and cure pediatric catastrophic diseases.

American Lung Association report examines the use of satellite-derived data to track unhealthy levels of NO

ROCKVILLE, Md., 6 mars 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), un partenaire de dveloppement de traitements de pointe du gne aux BPF, a annonc aujourd'hui la nomination de John Chiminski et de Karen Flynn en tant que membres non excutifs de son conseil d'administration. John sera le prsident du conseil d'administration et EW Healthcare Partners a dsign Karen pour siger au conseil d'administration de la socit en tant que l'un de ses reprsentants. Leur leadership et leur expertise approfondie du secteur seront essentiels pour permettre Ascend de renforcer ses capacits et de se positionner en vue de la croissance.

BARCELONA, Spain, March 6, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, together with China Unicom and YunHuan Technology, has been awarded the "Best Mobile Innovation for Cities" for their innovative "5G-A Smart City Low-Altitude Blood Delivery" project at the Global Mobile (GLOMO) Awards during MWC Barcelona 2025. The award recognizes their joint efforts in pioneering the commercial deployment of 5G-A Integrated Sensing and Communication technology in urban blood delivery.

LINKPING, Sweden, March 6, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that a US health system will expand its use of Sectra's enterprise imaging solution with digital pathology. The digital solution will enhance diagnostic speed by enabling pathologists to review and collaborate on cases more effectively. Moreover, using the same system to store and view images and information from various medical specialties enables integrated diagnostics, which is key for efficient cancer care.

SHANGHAI, March 6, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that the first patient has been dosed with the Company's internally developed personalized mRNA cancer vaccine EVM16 at Peking University Cancer Hospital in the investigator-initiated clinical trial (IIT) EVM16CX01. EVM16CX01 is the first-in-human (FIH) trial for EVM16, conducted jointly at Peking University Cancer Hospital and Fudan University Shanghai Cancer center, to assess the safety, tolerability, immunogenicity, and preliminary efficacy of EVM16 as a monotherapy and in combination with a PD-1 antibody in patients with advanced or recurrent solid tumors.

BARCELONA, Spain, March 6, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, together with China Unicom and YunHuan Technology, has been awarded the "Best Mobile Innovation for Cities" for their innovative "5G-A Smart City Low-Altitude Blood Delivery" project at the Global Mobile (GLOMO) Awards during MWC Barcelona 2025. The award recognizes their joint efforts in pioneering the commercial deployment of 5G-A Integrated Sensing and Communication technology in urban blood delivery.

SUZHOU, China, March 6, 2025 /PRNewswire/ -- On March 06, 2025, GenAssist Ltd (GenAssist), a pioneering gene-editing biotechnology company specializing in genome medicines, is thrilled to announce that it has received clearance from the U.S Food and Drug Administration(FDA) for its Investigational New Drug (IND) application for GEN6050X, a first-in-class base editing drug for Duchenne Muscular Dystrophy (DMD). GenAssist is planning to conduct clinical study globally for GEN6050X.

The Alliance for Women's Health & Prevention (PRNewsfoto/Alliance for Women's Health & Prevention) The EveryBODY Covered campaign logo. (PRNewsfoto/Alliance for Women's Health & Prevention)

EMERYVILLE, Calif., March 6, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, has entered into privately negotiated exchange and subscription agreements (the "Exchange Agreements") with a limited number of holders of its outstanding 2.50% Convertible Senior Notes due 2026 (the "2026 Notes") and one new investor, pursuant to which the Company will issue $225 million aggregate principal amount of 2.0% Convertible Senior Notes due 2030 (the "New Notes") comprised of (i) an exchange for the retirement of approximately $185 million in aggregate principal amount of existing 2026 Notes, and (ii) approximately $40 million of New Notes issued to existing holders and one new investor (the "Transactions").

Star athletes on the squad includeJohni Broome, Mark Sears, Madison Booker, and Lauren Betts